Further validation, replication of our findings, and comparative studies across different brain regions and FTLD subtypes are required to corroborate altered dynamics of these proteins in SD, as well as functional work to elucidate a possible interplay with pathological TDP-43 aggregate formation. This evidence concerns the gene TARDBP and Salla disease.